Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RETA crawled time : 22:00 save search
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: -0.33%
H: 0.35%
C: -1.5%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.67%
H: 0.85%
C: 0.21%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
ALDX | $3.91 -0.51% -0.51% 450K
|
Health Technology
|
| O: -1.8%
H: 0.46%
C: -2.44%
companies therapeutics growth market
Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia
Published: 2022-03-31 (Crawled : 22:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 2.04%
H: 6.09%
C: 3.97%
treatment drug application submission friedreich’s ataxia
Reata Pharmaceuticals, Inc. To Report First Quarter 2021 Financials and To Provide an Update on Development Programs on May 6, 2021
Published: 2021-04-28 (Crawled : 22:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -0.11%
H: 0.11%
C: -2.58%
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.